Gulf Pharmaceutical Industries

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: AEG000201018
AED
1.04
-0.01 (-0.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
273.40
279.40
249.70
348.10
281.90
239.50
236.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
273.40
279.40
249.70
348.10
281.90
239.50
236.90
Raw Material Cost
153.70
194.60
147.50
204.30
173.40
146.10
141.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.20
2.00
4.70
7.60
14.80
11.50
17.10
Selling and Distribution Expenses
84.70
63.00
89.00
112.30
90.70
65.20
83.20
Other Expenses
0.20
0.60
0.15
0.00
-0.84
-0.57
-1.04
Total Expenditure (Excl Depreciation)
243.60
265.60
242.70
324.20
270.50
217.10
231.00
Operating Profit (PBDIT) excl Other Income
29.8
13.799999999999999
7
23.900000000000002
11.399999999999999
22.400000000000002
5.8999999999999995
Other Income
5.30
-5.30
3.30
3.10
6.50
-6.70
0.10
Operating Profit (PBDIT)
45.40
18.40
27.30
42.60
33.40
42.90
42.30
Interest
3.20
2.00
4.70
7.60
14.80
11.50
17.10
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
119.70
84.80
102.20
143.80
108.50
93.40
95.80
Depreciation
10.30
9.90
17.00
15.60
15.50
27.20
36.30
Profit Before Tax
31.90
6.50
5.60
19.40
3.10
4.20
-11.10
Tax
3.50
-0.70
0.30
2.50
1.60
3.60
-1.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28.30
6.70
5.00
16.90
1.50
0.10
-10.10
Extraordinary Items
0.00
-0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
28.30
6.70
5.00
16.90
1.50
0.10
-10.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.10
0.50
0.30
0.00
0.00
0.50
0.80
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
28.40
7.20
5.30
16.90
1.50
0.60
-9.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
976.60
949.10
963.70
956.00
937.70
788.70
750.10
Earnings per share (EPS)
0.03
0.01
0.01
0.01
0.01
0.01
-0.01
Diluted Earnings per share
0.03
0.01
0.01
0.01
0.01
0.01
-0.01
Operating Profit Margin (Excl OI)
10.9%
4.94%
2.8%
6.87%
4.04%
9.35%
2.49%
Gross Profit Margin
15.44%
5.87%
9.05%
10.05%
6.6%
13.11%
10.64%
PAT Margin
10.35%
2.4%
2.0%
4.85%
0.53%
0.04%
-4.26%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -2.15% vs 11.89% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 294.44% vs 35.85% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 69.20% vs -1.25% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 60.00% vs -57.45% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Gulf Pharmaceutical Industries With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(AED)
Change(%)
Net Sales
273.40
0
273.40
Other Operating Income
0.00
0.00
0.00
Total Operating income
273.40
0
273.40
Raw Material Cost
153.70
0
153.70
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.20
0
3.20
Selling and Distribution Expenses
84.70
0
84.70
Other Expenses
0.20
0.00
0.20
Total Expenditure (Excl Depreciation)
243.60
0
243.60
Operating Profit (PBDIT) excl Other Income
29.80
0.00
29.80
Other Income
5.30
0
5.30
Operating Profit (PBDIT)
45.40
0
45.40
Interest
3.20
0
3.20
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
119.70
0
119.70
Depreciation
10.30
0
10.30
Profit Before Tax
31.90
0
31.90
Tax
3.50
0
3.50
Provisions and contingencies
0
0
0.00
Profit After Tax
28.30
0
28.30
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
28.30
0
28.30
Share in Profit of Associates
0
0
0.00
Minority Interest
0.10
0
0.10
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28.40
0
28.40
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
976.60
0
976.60
Earnings per share (EPS)
0.03
0
0.03
Diluted Earnings per share
0.03
0
0.03
Operating Profit Margin (Excl OI)
10.90%
0%
0.00
10.90%
Gross Profit Margin
15.44%
0%
0.00
15.44%
PAT Margin
10.35%
0%
0.00
10.35%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 27.34 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.15% vs 11.89% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -3.02% vs -35.80% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.84 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 294.44% vs 35.85% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 1,793.33% vs -31.82% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.01 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 69.20% vs -1.25% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 49.07% vs -46.09% in Mar 2025

Quarterly - Interest
Interest 0.32 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 60.00% vs -57.45% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -78.38% vs -16.85% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.90%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025